Today's Hours: 8:00am - 6:00pm


Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    edited by Michael J.P. Lawman and Patricia D. Lawman.
    Single Step Antigen Loading and Maturation of Dendritic Cells Through mRNA Electroporation of a Tumor-Associated Antigen and a TriMix of Costimulatory Molecules
    Generation of Multiple Peptide Cocktail-Pulsed Dendritic Cells as a Cancer Vaccine
    Pulsing Dendritic Cells with Whole Tumor Cell Lysates
    Antigen Trapping by Dendritic Cells for Anti-Tumor Therapy
    Ex Vivo Loading of Autologous Dendritic Cells with Tumor Antigens
    Tumor Antigen/Cytokine-Pulsed Dendritic Cells in Therapy Against Lymphoma
    Dendritic Cells Primed with Protein-Protein Fusion Adjuvant
    Antigen-Specific mRNA Transfection of Autologous Dendritic Cells
    Electroporation of Dendritic Cells with Autologous Total RNA from Tumor Material
    Dendritic Cells Transfected with Adenoviral Vectors as Vaccines
    Genetic Modification of Dendritic Cells with RNAi
    Fast Monocyte-Derived Dendritic Cells-Based Immunotherapy
    Intratumoral Injection of BCG-CWS Pretreated Dendritic Cells Following Tumor Cryoablation
    Exploiting the CD1d-iNKT Cell Axis for Potentiation of DC-Based Cancer Vaccines
    Modification of T Lymphocytes to Express Tumor Antigens
    Genetic Modification of Mouse Effector and Helper T Lymphocytes Expressing a Chimeric Antigen Receptor
    Genetic Modification of Cytotoxic T Lymphocytes to Express Cytokine Receptors
    Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients
    Cytokine Activation of Natural Killer Cells
    Loading of Acute Myeloid Leukemia Cells with Poly(I:C) by Electroporation
    Autologous Tumor Cells Engineered to Express Bacterial Antigens
    Tumor Cell Transformation Using Antisense Oligonucleotide
    The Direct Display of Costimulatory Proteins on Tumor Cells as a Means of Vaccination for Cancer Immunotherapy
    Cloning Variable Region Genes of Clonal Lymphoma Immunoglobulin for Generating Patient-Specific Idiotype DNA Vaccine
    Heat Shock Proteins Purified from Autologous Tumors Using Antibody-Based Affinity Chromatography
    Invariant Chain-Peptide Fusion Vaccine Using HER-2/neu
    TLR-9 Agonist Immunostimulatory Sequence Adjuvants Linked to Cancer Antigens
    Production of Multiple CTL Epitopes from Multiple Tumor-Associated Antigens
    Preparation of Polypeptides Comprising Multiple TAA Peptides
    Idiotype Vaccine Production Using Hybridoma Technology
    Preparation of Cancer-Related Peptide Cocktails that Target Heterogeneously-Expressed Antigens
    Making an Avipoxvirus Encoding a Tumor-Associated Antigen and a Costimulatory Molecule
    Bacterial Vectors for the Delivery of Tumor Antigens
    Preparation of Peptide Microspheres Using Tumor Antigen-Derived Peptides
    Production of Antigen-Loaded Biodegradable Nanoparticles and Uptake by Dendritic Cells
    Development of Plasmid-Lipid Complexes for Direct Intratumoral Injection
    The Use of Dendritic Cells for Peptide-Based Vaccination in Cancer Immunotherapy
    Advances in Host and Vector Development for the Production of Plasmid DNA Vaccines
    Challenges Facing the Development of Cancer Vaccines
    Future of Cancer Vaccines.
    Digital Access Springer 2014